Updated Outcomes from the Historical Control Study SCHOLAR-3 Contextualizing ZUMA-3 Results of Brexucabtagene Autoleucel (KTE-X19) in Adult Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL)

被引：2

作者：

Shah, Bijal D. ^{[1
]}

Ghobadi, Armin ^{[2
]}

Oluwole, Olalekan O. ^{[3
]}

Logan, Aaron C. ^{[4
]}

Boissel, Nicolas ^{[5
]}

Cassaday, Ryan D. ^{[6
]}

Leguay, Thibaut ^{[7
]}

Bishop, Michael R. ^{[8
]}

Topp, Max S. ^{[9
]}

Tzachanis, Dimitrios ^{[10
]}

O'Dwyer, Kristen M. ^{[11
]}

Arellano, Martha L. ^{[12
]}

Lin, Yi ^{[13
]}

Baer, Maria R. ^{[14
]}

Schiller, Gary J. ^{[15
]}

Park, Jae H. ^{[16
]}

Subklewe, Marion ^{[17
]}

Abedi, Mehrdad ^{[18
]}

Minnema, Monique C. ^{[19
]}

Wierda, William G. ^{[20
]}

DeAngelo, Daniel J. ^{[21
]}

Stiff, Patrick ^{[22
]}

Jeyakumar, Deepa ^{[23
]}

Dong, Jinghui ^{[24
]}

Adhikary, Sabina ^{[24
]}

Zhou, Lang ^{[24
]}

Schuberth, Petra C. ^{[24
]}

Faghmous, Imi ^{[24
]}

Masouleh, Behzad Kharabi ^{[24
]}

Houot, Roch ^{[25
,26
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[2] Washington Univ, Sch Med, St Louis, MO USA

[3] Vanderbilt Univ, Canc Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA

[4] UCSF Med Ctr, San Francisco, CA USA

[5] Hop St Louis, Paris, France

[6] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA

[7] CHU Bordeaux, Serv Hematol Clin & Therapie Cellulaire, Hop Haut Leveque, Bordeaux, France

[8] Univ Chicago Med, Chicago, IL USA

[9] Univ Klinikum WUrzburg, Med Klin & Poliklin 2, Wurzburg, Germany

[10] Univ Calif San Diego, San Diego, CA 92103 USA

[11] Univ Rochester, Wilmot Canc Inst, Rochester, NY USA

[12] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[13] Mayo Clin, Div Hematol, Rochester, MN USA

[14] Univ Maryland, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA

[15] UCLA, David Geffen Sch Med, Los Angeles, CA 90095 USA

[16] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[17] Ludwig Maximilians Univ Munchen, Munich, Germany

[18] Univ Calif Davis, Davis Comprehens Canc Ctr, Sacramento, CA 95817 USA

[19] Univ Med Ctr Utrecht, Behalf HOVON LLPC, Utrecht, Netherlands

[20] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[21] Dana Farber Canc Inst, Boston, MA USA

[22] Loyola Univ Chicago, Stritch Sch Med, Maywood, IL USA

[23] Univ Calif Irvine, Irvine Med Ctr, Orange, CA 92668 USA

[24] Kite, Santa Monica, CA USA

[25] Univ Rennes, INSERM, CHU Rennes, Rennes, France

[26] EFS, Rennes, France

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-158248

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3158 / 3161

页数：4

共 50 条

[31] KTE-C19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL): Outcomes in Patients Who Were Treated with Prior Blinatumomab in ZUMA-3
Shah, Bijal D.
Oluwole, Olalekan O.
Baer, Maria R.
Bishop, Michael R.
Holmes, Houston
Schiller, Gary J.
Donnellan, William
O'Dwyer, Kristen M.
Mardiros, Armen
Rossi, John M.
Shen, Tong
Xue, Allen
Jain, Rajul K.
Vezan, Remus
Wierda, William G.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S184 - S184
[32] CNCT19 for Treatment of Patients with Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-cell ALL) in Children and Adults
Wang, Ying
Chen, Xiaojuan
Wei, Shuning
Mi, Yingchang
Shi, Lin
Wang, Ying
Wang, Yongzeng
Haudenschild, Changting
Lv, Lulu
Zhu, Xiaofan
Wang, Jianxiang
BLOOD, 2021, 138
[33] Outcomes of patients (pts) treated with prior blinatumomab (Blin) in ZUMA-3: A study of KTE-C19, an anti-CD19 chimeric antigen receptor (CAR) t cell therapy, in adult pts with relapsed/refractory acute lymphoblastic leukemia (R/R ALL).
Shah, Bijal D.
Oluwole, Olalekan O.
Baer, Maria R.
Bishop, Michael Russell
Holmes, Houston Eccleston
Schiller, Gary J.
Donnellan, William Bruce
Carr-O'Dwyer, Kristen Marie
Mardiros, Armen
Rossi, John M.
Shen, Tong
Xue, Allen
Jain, Rajul K.
Vezan, Remus
Wierda, William G.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[34] Risk Factors Associated with Sub-Optimal Outcomes and Hematotoxicity Following Obecabtagene Autoleucel (obe-cel) for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL)
Sandhu, Karamjeet S.
Park, Jae H.
Shaughnessy, Paul
Logan, Aaron C.
Abedi, Mehrdad
Shah, Bijal
Bishop, Michael R.
Deangelo, Daniel J.
Brugger, Wolfram
Shang, Justin
Jabbour, Elias
Roddie, Claire
TRANSPLANTATION AND CELLULAR THERAPY, 2025, 31 (02):
[35] ZUMA-3: A phase 1/2 multi-center study evaluation the safety and efficacy of KTE-C19 anti-CD19 CAR T cells in adult patients with relapsed/refractory B precursor acute lymphoblastic leukemia (R/R ALL)
Shah, B.
Castro, J.
Goekbuget, N.
Kersten, M. Jose
Hagenbeek, T.
Wierda, W.
Schiller, G.
Bot, A.
Rossi, J. M.
Jiang, Y.
Navale, L.
Stout, S.
Aycock, J.
Wiezorek, J.
Jain, R.
ANNALS OF ONCOLOGY, 2016, 27
[36] KTE-C19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T cell Therapy in Adult Patients (Pts) With Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL) in the ZUMA-3 Trial: Preliminary Results of Novel Safety Interventions
Shah, Bijal
Stock, Wendy
Wierda, William
Topp, Max
Kersten, Marie Jose
Houot, Roch
Boissel, Nicolas
Holmes, Houston
Schiller, Gary
Mardiros, Armen
Rossi, John
Jiang, Yizhou
Shen, Tong
Aycock, Jeff
Stout, Shanna
Wiezorek, Jeff
Jain, Rajul
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S253 - S253
[37] Real World Treatment of Pediatric Patients with Down Syndrome and Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-All) Treated with Tisagenlecleucel
Pacenta, H.
Schultz, L.
Baggott, C.
Shah, N.
Prabhu, S.
Phillips, C.
Rossoff, J.
Stefanski, H.
Talano, J. -A.
Moskop, A.
Margossian, S.
Verneris, M.
Myers, G.
Karras, N.
Brown, P.
Qayed, M.
Hermiston, M.
Satwani, P.
Krupski, C.
Keating, A.
Wilcox, R.
Rabik, C.
Fabrizio, V.
Rouce, R.
Chinnabhandar, V.
Kunicki, M.
Barsan, V.
Goksenin, A.
Curran, K.
Mackall, C.
Laetsch, T.
PEDIATRIC BLOOD & CANCER, 2021, 68 : S87 - S88
[38] Sinusoidal Obstruction Syndrome in Patients with Relapsed/Refractory (R/R) b-cell Acute Lymphoblastic Leukemia (B-all) Treated with ari-0001 Cells
Ortiz-Maldonado, Valentin
Alonso-Saladrigues, Anna
Caballero-Banos, Miguel
Castella, Maria
Boronat, Anna
Garcia-Rey, Enric
Baumann, Tycho
Diaz-Beya, Marina
Torrebadell, Montserrat
Faura, Anna
Catala, Albert
Ramos, Federico
Palomino, Alicia
Gomez-Hernando, Marta
Jimenez-Vicente, Carlos
Cid, Joan
Lozano, Miquel
Llanos, Cristina
Tellez, Adrian
Fernandez, Sara
Castro, Pedro
Jordan, Iolanda
Esteve, Jordi
Maria Canals, Josep
Trias, Esteve
Yague, Jordi
Suarez-Lledo, Maria
Rovira, Montserrat
Urbano-Izpizua, Alvaro
Juan, Manel
Rives, Susana
Delgado, Julio
BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 235 - 236
[39] Bridging Therapy in Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Receiving Standard of Care Brexucabtagene Autoleucel: Results from the RealWorld Outcomes Collaborative of CAR T in Adult ALL (ROCCA)
Lin, Chenyu
Tsai, Stephanie B.
Roloff, Gregory W.
Zhang, Amy
Aldoss, Ibrahim
Kopmar, Noam E.
Dekker, Simone E.
Jeyakumar, Nikeshan
Gupta, Vishal K.
O'Connor, Timothy E.
Dykes, Kaitlyn C.
Ahmed, Mohamed
Dholaria, Bhagirathbhai
Zambrano, Hector
Bradshaw, Danielle
Logan, Aaron C.
Tracy, Sean
Kubiak, Michal
Solh, Melhem M.
Mercadal, Santiago
Schwartz, Marc
Mukherjee, Akash
Battiwalla, Minoo
Shaughnessy, Paul
Majhail, Navneet
Mountjoy, Luke
Malik, Shahbaz A.
Mathews, John
Ladha, Abdullah
Advani, Anjali S.
Stefan, Maryann
Guzowski, Caitlin
Hoeg, Rasmus T.
Hilal, Talal
Moore, Jozal
O'Dwyer, Kristen M.
Sasine, Joshua
Lee, Catherine J.
Kota, Vamsi K.
Koura, Divya
Veeraputhiran, Muthu
Blunk, Betsy
Leonard, Jessica T.
Oliai, Caspian H.
Bachanova, Veronika
Stock, Wendy
Pullarkat, Vinod
Cassaday, Ryan D.
Miller, Katharine
Muffly, Lori S.
BLOOD, 2023, 142
[40] Obecabtagene Autoleucel (obe-cel, AUTO1) for Relapsed/Refractory Adult B-cell Acute Lymphoblastic Leukemia (R/R B-ALL): Pooled Analysis of the Ongoing FELIX Phase Ib/II Study
Roddie, Claire
Sandhu, Karamjeet S.
Tholouli, Eleni
Shaughnessy, Paul
Barba, Pere
Guerreiro, Manuel
Bishop, Michael R.
Yared, Jean A.
Ghobadi, Armin
Yallop, Deborah
Logan, Aaron C.
Beitinjaneh, Amer M.
Pantin, Jeremy M.
Arellano, Martha
Chaganti, Sridhar
Malladi, Ram
Menne, Tobias
Escamilla Gomez, Virginia
Hodby, Katharine
Gundabolu, Krishna
Mountjoy, Luke
O'Dwyer, Kristen M.
Abedin, Sameem
Alkhateeb, Hassan
Shah, Bijal D.
Lao-Sirieix, Pierre
Pittari, Gianfranco
Saxena, Kapil
Zhang, Yiyun
Brugger, Wolfram
Pule, Martin A.
Park, Jae H.
DeAngelo, Daniel J.
Jabbour, Elias
BLOOD, 2023, 142

← 1 2 3 4 5 →